Topic: Bristol

Top 7 biology papers

The Scientist - 464 days ago
How fat causes diabetes There are new molecular links between obesity and diabetes-a high-fat diet in mice activates proteins associated with obesity, but these changes can be reversed by a well-known diabetes drug, suggesting the same pathway may also cause insulin-resistance. Free ...

Bristol-Myers gets drug approvals, awaits more

AP News - 471 days ago
Drugmaker Bristol-Myers expected to focus on new drug approvals, more on horizon in 3Q reportBristol-Myers Squibb Co., the maker of popular blood thinners Plavix and Coumadin, is likely to spend some time trumpeting its latest acquisition, plus two recent drug approvals and ...
Read More...

Earnings Preview: Bristol-Myers to discuss R&D

AP News - 564 days ago
Bristol-Myers expected to focus on drug research progress, approval prospects in 2Q reportDrugmaker Bristol-Myers Squibb Co. is expected to focus on a raft of recent positive research data and plans to seek approval for several drugs when it reports its second-quarter results ...
Read More...

Bristol-Myers gets EU approval for diabetes drug

AP Features - 853 days ago
Drugmaker Bristol-Myers Squibb Co. said Monday that its new diabetes drug, Onglyza, has been approved for sale in the European Union's 27 countries.That means Onglyza will compete with Merck & Co.'s blockbuster diabetes drug Januvia both in the EU and in the ...
Read More...

Being Second In Line No Hurdle In Pharma

Investors Business Daily - 1021 days ago
Bristol and Astra are co-developing saxagliptin, a DPP4 inhibitor designed to control high blood sugar by increasing insulin secretion while slowing digestion.. If the Food and Drug Administration gives the drug a thumbs-up, Bristol will give it a trade name, Onglyza, and ...